Aim: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities and a predictor of both type 2 diabetes mellitus and adverse cardiovascular events. Whether there are gender differences in the association between early atherosclerosis and MetS has not yet been thoroughly elucidated. Methods: The subjects consisted of 388 men aged 64 16 years and 480 women aged 70 13 years. Early atherosclerosis was assessed by carotid intima-media thickness (IMT) on B-mode ultrasonography. Results: Carotid IMT values were significantly greater in both male (P 0.007) and female (P 0.002) subjects with MetS. After adjusting for established risk factors, the difference persisted on a significant level in women (P 0.003), but was weak in men (P 0.013). Multiple regression analysis using IMT as an objective variable, with adjustment for various risk factors as explanatory variables, showed that MetS (P 0.016) was a significant independent contributing factor along with known risk factors only in women. Among the components of MetS, hypertension (P 0.036) and dyslipidemia (P 0.008) had a strong impact on carotid IMT in men, whereas hypertension (P 0.003) ranked first in women. Conclusion: The effect of MetS in early carotid atherosclerosis is more pronounced in women than in men, and the impact of MetS components on carotid IMT differs between men and women. 
Introduction
Metabolic syndrome (MetS) is a cluster of metabolic abnormalities involving the several cardiovascular risk factors. These include visceral obesity, hypertension, hypertriglyceridemia, a low level of high-density lipoprotein cholesterol (HDL-C), and impaired glucose tolerance 1, 2) . Several epidemiologic studies have shown a link between MetS and subsequent cardiovascular disease (CVD) as well as type 2 diabetes mellitus in the general population [3] [4] [5] . The prevalence of dyslipidemia and impaired glucose tolerance is considerably higher in older women than it is in older men 6) en were, however, found to outlive men and to experience fewer atherosclerotic CVD events, with an incidence lagging behind that in men by 10 to 20 years. This gap in incidence closes with advancing age, when CVD becomes the leading cause of death in both women and men 7) . Several studies have suggested that type 2 diabetes mellitus increases the risk for CVD in women to a greater extent than it does in men [8] [9] [10] , but there are fewer studies demonstrating gender differences for the association of MetS and subclinical atherosclerosis 11) . The present study first ascertains the correlations of MetS in a representative sample of inpatients and then demonstrates gender differences in the association of MetS with early measures of carotid intima-media thickness (IMT) on B-mode ultrasonography. To examine these two issues, we used cross-sectional data from the participants.
Materials and Methods

Patients
The subjects were inpatients consecutively admitted to the Medical Department of Seiyo Municipal Nomura Hospital between August 1996 and January 2006. Patients with established coronary heart disease, cerebrovascular disease, or congestive heart disease were excluded. Informed consent for the procedure was obtained from each patient. All procedures were approved by the Ethics Committee of Seiyo Municipal Nomura Hospital. The subjects comprised 388 men aged 64 16 (range: 14-97) years and 480 women aged 70 13 (range: 17-104) years.
Ultrasound Image Analysis
An ultrasonograph (Hitachi EUB-565 or Aloka SSD-2000) equipped with a 7.5-MHz linear-type Bmode probe was used by a specialist in ultrasonography to evaluate sclerotic lesions of common carotid arteries within 2 days of blood biochemistry analysis. Patients were asked to assume a supine position; then both carotid arteries were observed obliquely from the anterior and posterior directions. We measured the thickness of the intima-media complex on the far wall of the bilateral common carotid artery about 10 mm proximal to the bifurcation of the carotid artery (as the image at that site is more clearly depicted than that at the near wall) 12, 13) as well as the wall thickness near the 10-mm point on the B-mode monitor. We then used the mean value for analysis.
For the ultrasonographic (Hitachi EUB-565 or Aloka SSD-2000) evaluation of fat thickness using a 7.5-MHz linear-type B-mode probe, the subjects were placed in a supine position and the probe held perpendicular to the skin at the epigastrium, with vertical scanning performed along the abdominal median from the xiphoid process to the umbilicus to measure the maximal thickness of preperitoneal fat (P max) at the anterior surface of the liver 14) . Patients with a history of upper abdominal surgery were excluded to avoid any possible effect on the measurement of fat thickness. Visceral obesity was shown as P max 6.9 mm in men or 10 mm in women (equal to visceral fat accumulation 100 cm 2 as measured by computed tomography [15] [16] [17] [18] ).
MetS
We applied condition-specific cutoff points for MetS based on the guidelines, with modifications, for the diagnosis of this condition in Japan 18) . MetS was defined as visceral obesity assessed by ultrasonography and at least two of the following three conditions: hypertension, dyslipidemia and impaired fasting glucose.
Hypertension was defined as systolic blood pressure (SBP) 130 mmHg or diastolic blood pressure (DBP) 85 mmHg or those who had been treated for hypertension. Dyslipidemia was defined as triglyceride (TG) concentrations 150 mg/dL, HDL-C 40 mg/ dL or those who had been treated for dyslipidemia. Impaired fasting glucose was defined as fasting plasma glucose 110 mg/dL, or those who have been treated for diabetes.
Various Other Risk Factors
We measured blood pressure (BP) in the right upper arm of each patient (in a seated position) using a standard sphygmomanometer or an automatic oscillometric blood pressure recorder. Height and weight, measured by standard procedures, were used to calculate body mass index (BMI) as weight in kilograms divided by the square of height in meters. Cigarette smoking was quantified based on daily consumption and duration of smoking. For blood biochemistry analyses, total cholesterol (T-C), TG, and HDL-C, and uric acid were measured under 12-hour fasting conditions within 24 hours of admission. The level of lowdensity lipoprotein cholesterol (LDL-C) was calculated by the Friedewald formula 19) , and those with TG levels 400 mg/dL were excluded. The history of antihypertensive and/or antilipidemic drug use was also evaluated. The presence or absence of diabetes mellitus was diagnosed at the first examination using a 75-g oral glucose tolerance test. Patients who had been previously treated for diabetes mellitus were also defined as diabetic.
Statistical Analysis
Statistical analysis was performed using SPSS 10.0 J (Statistical Package for Social Science, Inc., Chicago). Differences between two groups defined by the presence or absence of MetS were analyzed by the MannWhitney U-test or the Chi-square test. General linear model analysis was used to assess intergroup differences of IMT between subjects with and without MetS after adjustment for relevant covariates. The relation between risk factors, including MetS and IMT, was examined by multiple linear regression analysis. Logistic regression analysis was used to assess the association of carotid atherosclerosis (carotid IMT 1.00 mm) with MetS. Assessment was conducted before and after adjustment for established risk factors. The effect size Eta 2 was used to analyze individual associations of MetS components with carotid IMT. A value of P 0.05 was considered significant.
Results
Characteristics of Patients/Subjects with and without MetS
MetS was present in 143 of 388 men (36.9%) and 112 of 480 women (23.3%). Table 1 shows the clinical and biochemical characteristics of the study participants. Several differences between subjects with and without MetS were found, involving the components of MetS as well as other risk factors, specifically BMI and LDL-C. There were no intergroup differences in age, smoking status, prevalence of antilipidemic drug use, or level of uric acid. There were significant differences (P 0.001) in the clustering of MetS between men as opposed to women: 73 men (18.8%) presented with one MetS component, 127 men (32.7%) with two components, 111 (28.6%) with three components, and 55 (14.2%) with four components. The corresponding numbers among women were 120 (25.0), 186 (38.8%), 101 (21.0%), and 39 (8.1%). Significantly more males fulfilled the criteria for visceral obesity (P 0.001) and dyslipidemia (P 0.001); however, hypertension (P 0.011) was observed in more women than men. Differences for TG and blood glucose were not significant.
Carotid Atherosclerosis by MetS
Carotid IMT values were significantly greater among both men (P 0.007) and women (P 0.002) with MetS, and the prevalence of carotid atherosclerosis (carotid IMT 1.00 mm) was also significantly more among both men (P 0.016) and women (P 0.019) with MetS ( Table 2) . among both men (P 0.002) and women (P 0.003), whereas -after adjustment for established risk factorsthe difference persisted on a significant level in women (P 0.003), but was weak in men (P 0.013).
Association between Various Characteristics and Carotid Intima-Media Thickness
Multiple regression analysis, using IMT as an objective variable and adjusted for various risk factors as explanatory variables, showed that MetS (P 0.016), was a significant independent contributing factor along with known risk factors such as age (P 0.001), systolic BP (P 0.002), LDL-C (P 0.001), HDL-C (P 0.015), and uric acid level (P 0.005) in women; however, MetS was not a significant independent contributing factor in men (Table 4) .
Odds Ratio of Carotid Atherosclerosis Associated with Components of Metabolic Syndrome
In the component model shown in Table 5 , hypertension (P 0.001) and dyslipidemia (P 0.003) were significant factors in men, and hypertension (P 0.001) and impaired fasting glucose (P 0.044) were significant in women. Moreover, for each disease definition, models after adjustment for age, BMI, smoking status, LDL-C, and uric acid level by logistic regression analysis are presented. Among the components of MetS, hypertension (P 0.036) and dyslipidemia (P 0.008) showed the strongest impact on carotid IMT in men, whereas hypertension (P 0.003) ranked first in women.
Association of Carotid Atherosclerosis (Carotid IMT 1.00 mm) with MetS: Crude and Adjusted Odds Ratios (OR) and 95% CIs
In these subjects, multiple logistic regression analysis for carotid atherosclerosis (carotid IMT 1.00 mm) was performed using age, BMI, smoking status, LDL-C, uric acid level, and MetS as variables. In unadjusted models for both groups, MetS was significantly associated with carotid IMT values. After adjustment for age, BMI, smoking status, LDL-C, and uric acid level, the odds ratio for carotid IMT values greater than 1.0 mm remained significant in women [odds ratio (OR), 2.03; 95% confidence interval (CI), 1.17-3.51], but not in men (OR, 1.65; 95% CI, 1.00-2.72). Fig. 1 outlines crude and adjusted ORs and 95% CIs.
Discussion
The present study examined gender differences in the association between MetS and early carotid atherosclerosis in patients with risk factors and demonstrated that carotid IMT was significantly higher in both men and women with MetS than in those without MetS. Multivariate analysis demonstrated that in women only, the association between MetS and carotid IMT was independent of other risk factors such as age, BMI, smoking status, LDL-C, and uric acid.
The impact of MetS and the components of MetS on carotid IMT have been reported to differ between men and women. Iglseder et al. 11) showed that carotid IMT parameters were significantly higher in subjects with MetS; after adjustment for established OR, odds ratio; CI, confidence interval. MetS was defined as visceral obesity assessed by ultrasonography and at least 2 of the following 3 conditions: hypertension, dyslipidemia (hypertriglycedemia, low HDL cholesterolemia or antilipidemic drug use) and impaired fasting glucose including patients previously treated for diabetes mellitus. Adjusted for age, body mass index, smoking status, low-density lipoprotein cholesterol and uric acid.
risk factors, the difference in carotid IMT between subjects with and without MetS remained significant only in women. The strength of the association between MetS variables and carotid IMT for middle-aged women differed from that for middle-aged men. Moreover, HDL-C among the components of MetS showed the strongest impact on carotid IMT in men, whereas blood glucose ranked first in women. Fan also reported gender-based differences in the mechanisms of metabolic syndrome-induced atherosclerosis 20) . Central obesity was significantly associated with baseline IMT for men only, whereas an elevated level of TG was significantly associated with the progression of IMT in women only. Systolic BP was significantly associated with the baseline and progression in both men and women. Smoking was associated with an increased risk of atherosclerotic plaque in both men and women 21) . In this study, IMT was independently associated with age, SBP, LDL-C, and HDL-C in both men and women, and associations with smoking status and diabetes mellitus were demonstrated only in men. In contrast, associations were found with uric acid level and MetS in women.
We cannot explain the mechanism underlying the gender-related difference shown in this study. A partial explanation may involve the influence of sex hormones 22) . In their study, Iemolo et al. 22) found that the prevalence of MetS-associated coronary heart disease in women aged 35 to 54 years was almost the same as that in the control group, whereas in women aged 55 to 74 years and in men aged 35 to 74, this prevalence was about twice that of the control group 23) . In several studies, estrogen was thought to be related to an improvement in traditional risk factors, such as elevated levels of lipoproteins 24, 25) . Following menopause, adverse lipid changes occur and the levels of several coagulation factors increase. These findings suggest that atherosclerotic protection in women in the present study, most of whom were postmenopausal, was lost in the presence of MetS. However, in the study of Tanno and Sobetsu, 6-year follow-up for the occurrence of cardiac disease showed a greater number of events in male subjects with MetS than in those without MetS 26) . In our study, the difference in carotid IMT between subjects with and without MetS persisted on a significantly higher level in both men and women after adjustment for established risk factors. However, on multiple regression analysis using carotid IMT as an objective variable, MetS was not an independent risk factor in men. Differences in MetS criteria and the ages of subjects as well as the presence of confounding risk factors might also affect the result. In addition, MetS is associated with other atherosclerotic risk factors, when known risk factors were controlled for in multivariate analysis, the association of MetS with this early measure of carotid atherosclerosis might have become negligible in men; therefore, our findings suggest that metabolic syndrome may have more influence on carotid IMT in women than in men.
It is important to be aware of limitations in interpreting the present findings. First, since all participants were hospitalized patients, we could not eliminate the possibility of effects from underlying diseases and from medications. In our study, the prevalence of carotid atherosclerosis and MetS was greater than those shown in population-based studies in Japan 27, 28) . Second, we also could not eliminate the possible effects of differences in MetS criteria and medications for hypertension and dyslipidemia on the present findings. Third, the present data were obtained by cross-sectional study, thereby precluding temporality and casual inference; however, there are also some advantages of this study design that are worth noting. First, we were able to examine an extensive array of atherosclerotic risk factors in relation to MetS. Second, the relatively large sample size enabled the assessment of gender differences in the association of MetS with carotid atherosclerosis. Third, noninvasive ultrasound imaging of the carotid IMT provided a direct measure of atheroma development, thus enabling the study of the association of MetS with atherosclerosis without interference of thrombosis 29) . These points need to be addressed again in a prospective fashion in a large population-based sample.
In conclusion, we propose that MetS may be a risk factor for ultrasonographically determined early carotid atherosclerosis in women but not in men.
